News
Zoom out: The positive results sent Lilly's stock soaring 16% Thursday to $852. Bank of America's Anderson projected 2030 ...
Shares of Eli Lilly jumped 16% Thursday morning after the pharmaceutical company released clinical trial results for its oral ...
Eli Lilly GLP-1 pill orforglipron could revolutionize the weight loss world by the end of 2025 after promising Phase 3 trial ...
Lilly shares are up 14.2% in response to the news, while shares of its rivals in the GLP-1 weight loss market, Novo Nordisk ( ...
The first GLP-1 pill could be in medicine cabinets sooner than expected. Eli Lilly (LLY) announced Thursday that its daily ...
The company's breakthrough puts the market one step closer to having an injection-free alternative for the treatment of ...
Shares in pharmaceuticals firm Eli Lilly (LLY) ballooned higher today after revealing its new needle-free weight loss drug had performed ...
REUTERS Lilly’s stock ... version of weight loss drugs could pose a threat to the market dominance of Ozempic and Wegovy, which are available only in injectionable form. Getty Images Should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results